It has been shown that NO protects endothelial cells (EC) against H2O2-induced toxicity. In addition, it is known that NO within cells induces a zinc release from proteins containing zinc-sulfur complexes. The aim of this study was to investigate whether zinc released intracellularly by NO plays a signaling role in the NO-mediated protection against H2O2 in rat aortic EC. Our results show that the NO-mediated protection toward H2O2 depends on the activities of glutathione peroxidase and glutamate cysteine ligase (GCL), the rate-limiting enzyme of glutathione (GSH) de novo biosynthesis. Moreover, NO increases the synthesis of the antioxidant GSH by inducing the expression of the catalytic subunit of GCL (GCLC). Chelating intracellular "free" zinc abrogates the NO-mediated increase of GCLC and of cellular GSH levels. As a consequence, the NO-mediated protection against H2O2-induced toxicity is impaired. We also show that under proinflammatory conditions, both cellular NO synthesis and intracellular "free" zinc are required to maintain the cellular GSH levels. Using RNA interference and laser scanning microscopy, we found that the NO-induced expression of GCLC depends on the activation of the transcription factor Nrf2 but not on the activity of the "zinc-sensing" transcription factor MTF-1. These findings show that intracellular "free" zinc plays a signaling role in the protective activity of NO and could explain why maintenance of an adequate zinc status in the endothelium is important to protect from oxidative stress and the development of vascular disease. inducible nitric oxide synthase; zinc signaling; oxidative stress; glutamate cysteine ligase; Nrf2
OXIDATIVE STRESS AND CHRONIC INFLAMMATION have been recognized to promote endothelial dysfunction and/or damage, which represent the initial steps in the development of chronic vascular diseases, such as atherosclerosis (41) . Endothelial cells (EC) are particularly well equipped with defense mechanisms for the detoxification of radicals and xenobiotics (70) . The most abundant endogenously produced antioxidant in eukaryotic cells is the tripeptide glutathione (GSH), which is mainly responsible for the maintenance of the cellular redox state (20, 44, 73) . Selective inhibition of enzymes belonging to the GSH redox cycle increase the susceptibility of EC to H 2 O 2 -mediated cell damage (21) . GSH exerts its antioxidant activity by directly scavenging radical species, as well as by participating in reactions catalyzed by antioxidant enzymes such as glutathione peroxidase (GPx) (20, 44, 73) . The total cellular GSH concentration (0.5-10 mM) is determined by the rate of GSH de novo synthesis, the cellular capacity to recycle GSH, and the rate of cellular GSH export (20, 44, 73) . The rate-limiting step of the GSH de novo synthesis is catalyzed by glutamate-cysteine ligase (GCL; EC 6.3.2.2), a heterodimer composed of a catalytic heavy chain (GCLC) and a modifier (or regulatory) light chain (GCLM) (16) . Changes in GCL activity may result from regulation at multiple levels affecting either the catalytic or the modifying subunit, or both. Heritable deficiency of antioxidant enzymes and, particularly, of both GCLC and GCLM imposes a status of oxidative stress on the vasculature and may be associated with an increased risk to develop vascular diseases (16, 29, 38, 54) .
The transcription of human (15, 71) and mouse (7, 8) GCLC is mainly regulated by the transcription factor Nrf2 (nuclear factor, erythroid-derived 2, like-2) (48) . Nrf2 binds to the antioxidant responsive element (ARE; also defined as electrophile response element), which has been identified in the promoter regions of human, mouse, and, recently, rat GCLC (7, 40, 48, 51) . Adenovirus-mediated overexpression of Nrf2 increases intracellular GSH levels in human EC (10) . The antioxidant activity of zinc and nutritional antioxidants is strongly dependent on the activation of Nrf2 and, particularly, on their ability to regulate the expression of the genes encoding the subunits of GCL (12, 16, 49) .
During inflammation, the inducible form of nitric oxide synthase (iNOS) is expressed in EC, resulting in high-output synthesis of nitric oxide (NO). Whether iNOS-derived NO plays a deleterious or a protective role in endothelial injury has not been established yet. iNOS-deficient mice are more prone to atheroma formation (25) , and overexpression of iNOS inhibits experimental vascular lesion formation (69) . High-output NO synthesis achieved by adding NO donors or by inducing the expression of iNOS by treating EC with proinflammatory cytokines protects EC against H 2 O 2 -induced toxicity by inhibiting lipid peroxidation (58, 63) , iron uptake (9, 30) , and cytochrome c release and by inducing the expression of protective proteins (50, 63, 65) . Application of NO donors also has been shown to induce GSH synthesis in EC by inducing the expression of GCLC (46, 47) and by controlling the cystine uptake (39) .
Both NO donors and iNOS-derived NO induce intracellular zinc release from zinc sulfur clusters as found in proteins such as metallothionein (5, 33, 45, 55, 59 -62) . Thus NO may be involved in the control of the intracellular zinc homeostasis (31, 32) . We recently demonstrated that exogenously added zinc, similarly to NO, induces the synthesis of GSH by controlling the expression of GCLC and in this way protects EC against H 2 O 2 -induced toxicity (12) . In the present study we investigated whether "free" zinc released by NO within the cells plays a signaling role in the NO-mediated protection against H 2 O 2 in EC.
MATERIALS AND METHODS

Materials.
Unless otherwise specified, chemicals were purchased from Merck (Darmstadt, Germany). Cell culture material was purchased from PAA Laboratories (Pashing, Austria); recombinant cytokines from Strathmann Biotech (Hannover, Germany); nonfat dry milk from Bio-Rad (Munich, Germany); materials for Western blots (NuPAGE LDS sample buffer, NuPAGE reducing agent, and NuPAGE 7% Novex Tris-acetate precast gels) from Invitrogen (Karlsruhe, Germany); Ponceau S from SERVA Electrophoresis (Heidelberg, Germany); Hybond P transfer membrane from Amersham Biosciences (Munich, Germany); anti-human GCLC rabbit antiserum from Dunn Labortechnik (Asbach, Germany); mouse monoclonal anti-human ␤-actin antibody, horseradish peroxidase (HRP)-conjugated goat anti-mouse antiserum, and HRP-conjugated goat anti-rabbit antiserum from BD Biosciences (Erembodegem, Belgium); rabbit anti-human Nrf2 antiserum from Santa Cruz Biotechnology (Santa Cruz, CA); and goat anti-rabbit antiserum conjugated with AlexaFluor 594 from Invitrogen. The NO donor (Z)-1-[N-(2-aminoethyl)-N-(2-aminoethyl)amino]diazen-1-ium-1,2-diolate (DETA/NO) was synthesized as described previously (24) .
Cells. Aorta was explanted from male Wistar rats ϳ30 days old and of 150-g body weight, obtained from the Heinrich-Heine-University of Düsseldorf breeding facility. The procedure was conducted in conformity with the American Physiogical Society's "Guiding principles for research involving animals and human beings" and was approved by the ethical committee of the Heinrich-Heine-University. Rat aorta EC were isolated by outgrowth from aortic rings, expressed the phenotype vWF high Ox43high eNOShigh (64) , and were cultured in RPMI 1640 -10% fetal bovine serum (FBS).
Zinc determination. The zinc concentrations of media and buffers were determined by flame atomic adsorption spectrometry as described previously (12) .
Experimental procedures. Measurements were performed with EC from passages 2-8. Viability of the cells was assessed routinely at the beginning and at the end of every experiment by using the trypan blue exclusion assay. Cells were cultured for 24 h in RPMI 1640 -10% FBS in 12-well tissue culture plates (5 ϫ 10 5 cells/well) in the absence or presence of the NO donor DETA/NO or with proinflammatory cytokines inducing endogenous NO synthesis or the respective controls at the concentrations indicated. After washing, oxidative stress-mediated cell death was induced by a 24-h incubation with 0.2-1.4 mM H 2O2. The effectiveness of the H2O2 treatment was controlled by adding 2,000 units of catalase. Cell viability was detected by neutral red staining and is expressed as the percentage of live H 2O2-treated vs. untreated cells. Apoptosis or necrosis was detected by staining the DNA with H33342 dye and by detecting DNA strand breaks in acetone-fixed cells by using the in situ nicktranslation method, as described previously (56) . Where indicated, the catalase inhibitor 3-amino-1,2,3-triazole (ATA; 0.5 mM), the glutathione peroxidase inhibitor ␤-mercaptosuccinic acid (MS; 1 mM), or the GCL inhibitor L-buthionine sulfoximine (BSO; 0.05 mM) was added together with H 2O2. Stock solutions of ATA and BSO (100 mM) were prepared in double-distilled H 2O and then diluted in the culture medium. The MS stock solution (100 mM) was diluted in complete medium with 20 mM HEPES to equilibrate the pH.
To deplete the cells of zinc during the treatment with the NO donor or proinflammatory cytokines, we added a nontoxic concentration of the membrane-permeable zinc chelator N,N,NЈ,NЈ-tetrakis(2-pyridylmethyl)ethylenediamine (TPEN; 3.3 M) to the culture medium (containing 2.28 Ϯ 0.32 M Zn 2ϩ ). The effect of the TPEN treatment on cell viability was determined by neutral red staining and by analyzing the nuclear morphology after staining the DNA with H33342. The cell viability of TPEN-treated cells compared with untreated cells was 100% Ϯ 9.2% (n ϭ 8). As a control for zinc specificity, equimolar concentrations of ZnSO 4 (3.3 M) were added together with TPEN. To control whether extracellular zinc plays any role, we prepared a zinc-depleted medium by using Chelex 100 as described previously (22, 23, 57) . Briefly, FBS (containing 24.98 Ϯ 2.00 M Zn 2ϩ ) was treated with Chelex-100 chelating resin according to the manufacturer's instructions and then mixed with RPMI 1640. The zinc concentration of RPMI 1640 with 10% Chelex-FBS was found to be below the detection limit (1.0 M Zn 2ϩ ) of flame atomic adsorption spectrometry. Therefore, it was termed "low-zinc" medium, although Chelex removes other divalent metal ions as well.
Laser scanning microscopy. To determine whether the NO donor DETA/NO induces Nrf2 translocation into the nucleus, we stained EC (1 ϫ 10 4 cells/well) with rabbit anti-human Nrf2 antiserum (1:100) together with goat anti-rabbit antiserum conjugated with AlexaFluor 594 (1:250), as described previously (12) . Nuclei were stained with the DNA stain H33342 (7 g/ml). Coverslips were analyzed under a Zeiss laser scanning microscope 510 with the use of a Zeiss Plan Neofluar ϫ40/1.3 oil differential interference contrast objective.
Real-time RT-PCR and gene-silencing experiments. Gene expression was determined using TaqMan universal PCR master mix in a ABI PRISM 7900 system (Applied Biosystems, Foster City, CA). The following primers and probes were purchased from Applied Biosystems: GCLC subunit (Gclc; NM_012815, assay Rn00563101-m1), heme oxygenase (decycling) 1 (Ho1; NM_012580, assay Rn00561387-m1), zinc transporter-1 (Znt1; NM_022853, assay Rn00575737-m1), and 18s rRNA, which was chosen as a housekeeping gene. The small interference RNA (siRNA) sequences targeting Nrf2 or Mtf1 transcription factors were designed and synthesized by Qiagen, as previously described (12) . As a control for unspecific effects, a nonsilencing siRNA sequence was used (Qiagen). The positive control was a siRNA sequence directed against Gapdh mRNA (Ambion, Huntingdon, UK). The best silencing efficiency was obtained by transfecting 1.5 ϫ 10 5 cells with 5 nM siRNA and 9 l of HiPerfect transfection reagent (Qiagen) following the manufacturer's instruction. After 48 h, the culture medium was changed and the cells were treated with DETA/NO, proinflammatory cytokines, or the respective control treatments as indicated. The mRNA levels of Nrf2, Mtf1, and Gapdh were determined using a QuantiTect SYBR green PCR kit (Qiagen) and 18s rRNA as a housekeeping gene. Primers were designed with Primer Express software 2.0 (Applied Biosystems) as described previously (12) . Results were analyzed following established procedures (52) . Forty-eight hours after transfection, a fourfold decrease of the Nrf2 mRNA and a threefold decrease of the Mtf1 mRNA were detected (data not shown).
Determination of the total intracellular glutathione concentration. EC were cultured in 100-mm petri dishes (1 ϫ 10 7 cells) for 24 h and treated as indicated. Total cellular glutathione (GSH ϩ GSSG) was determined photometrically by measuring the formation of 5-thio-2-nitrobenzoic acid from 5,5Ј-dithionitrobenzoic acid in the presence of NADPH and glutathione reductase (1) at 405 nm using a FLUOstar OPTIMA plate reader (BMG Labtech, Offenburg, Germany). The amount of total glutathione was normalized to the protein content (expressed as mol GSH/mg protein).
Western blot analysis. EC were cultured in six-well plates (1.5 ϫ 10 6 cells/well) and treated as indicated. Cells were lysed with RIPA lysis buffer (1% Nonidet-P 40, 0.5% sodium deoxycholate, and 0.1% SDS in phosphate-buffered saline) containing Complete mini protease inhibitors (Roche Diagnostic). The protein content was determined using the DC protein assay (Bio-Rad). Samples (30 g) were separated in a 7% NuPAGE Novex Tris-acetate gel and then transferred on Hybond P membranes. Membranes were stained with either rabbit anti-GCL antiserum (2.5 g/ml) or mouse monoclonal anti-human ␤-actin antibodies (1:5,000) and were then incubated with HRPconjugated goat anti-rabbit antibodies (1:5,000) or HRP-conjugated goat anti-mouse antiserum (1:5,000). The bands were visualized by autoradiography on a Hyperfilm ECL (Amersham Biosciences) using SuperSignal West Pico chemiluminescent substrate (Pierce).
Statistical analysis. Real-time PCR data were processed as described previously (52) . Data are means Ϯ SE. Statistical comparisons were carried out with one-way or two-way ANOVA, followed by an appropriate post hoc comparison test (Tukey's, Dunnett's, or Student's t-test). Fig. 2A ). The NO-mediated protection cannot be related to a direct scavenging effect of NO on H 2 O 2 , because DETA/NO in culture medium has a half-life of ϳ7-8 h (5). According to first-order kinetics, 1 mM DETA/NO generates 3.3 nM NO per minute. This is similar to a steady-state concentration of ϳ4 -5 M NO, which has been calculated to be present in the immediate vicinity of a cell monolayer that enzymatically generates NO (37) .
RESULTS
NO-mediated protection of EC against H
To determine whether catalase or GPx, both of which catalyze the reduction of H 2 O 2 to H 2 O, plays a role in the NO-mediated protection toward H 2 O 2 , we cultured untreated cells or cells pretreated with DETA/NO in the presence of 1 mM H 2 O 2 together with specific inhibitors of these enzymes, i.e., MS (1 mM) or ATA (0.5 mM). As also recently reported by our group (9), addition of nontoxic concentrations of these inhibitors significantly increased the toxicity of H 2 O 2 in otherwise untreated cells (Fig. 1A, lanes 3 and 4 vs. lane 2, open  bars) . In cells pretreated with DETA/NO, inhibition of catalase by ATA did not exert any effect on the NO-mediated protection (Fig. 1A, lane 3 vs. lane 2, filled bars) . In contrast, inhibition of GPx by MS nearly completely abolished the NO-mediated protection against H 2 O 2 (Fig. 1A, lane 4 vs. lane 2, filled bars). The role of GCL, the rate-limiting enzyme of GSH biosynthesis, was investigated by adding the specific inhibitor BSO (50 M). When GCL was inhibited during the treatment with H 2 O 2 , the toxicity of the H 2 O 2 treatment was strongly increased (Fig. 1A, lane 5 vs. lane 2, open bars) . However, protection conferred by pretreatment with DETA/NO was not affected (Fig. 1A , lane 5 vs. lane 2, filled bars).
If protein synthesis was inhibited during the pretreatment with DETA/NO by addition of the translation inhibitor cycloheximide, NO-mediated protection was significantly impaired (Fig. 1B, lane 3 vs. lane 2) , suggesting that NO induces the expression of protective proteins. If the cells were preincubated with the GCL inhibitor BSO before the treatment with H 2 O 2 , the toxicity of H 2 O 2 was strongly enhanced (Fig. 1B, lane 6 vs. lane 1) , and a pretreatment with DETA/NO under these conditions did not protect the EC from H 2 O 2 -induced toxicity (Fig.  1B, lane 5 vs. lane 1) . Thus the activities of GPx and GCL, enzymes belonging to the GSH redox cycle, are essential for the DETA/NO-mediated protection of EC against H 2 O 2 .
NO protects EC against H 2 O 2 -induced toxicity and increases the cellular GSH levels via intracellular "free" zinc.
To examine the role of zinc in the NO-mediated protection from H 2 O 2 , we depleted the culture medium of zinc (and other divalent metals) by treating the serum with the ion exchange resin Chelex or added the cell-permeable zinc chelator TPEN, which chelates intra-and extracellular zinc (K d for Zn 2ϩ -TPEN: 6.3 ϫ 10 Ϫ16 M at pH 7.6) (13, 27) . The TPEN concentration (3.3 M) chosen for the experiments in this study overwhelms the zinc concentration found in the culture medium containing 10% FBS (2.3 Ϯ 0.3 M Zn 2ϩ as determined by atomic adsorption spectrometry) and did not result in cytotoxicity after a 24-h incubation, as shown previously (12), but increased cytotoxicity following a 24-h incubation with H 2 O 2 ( Fig. 2A) . High intracellular output of NO was achieved by treating the cells with proinflammatory cytokines (IL-1␤ ϩ IFN␥), which induces the expression of iNOS (64) after 6 h of incubation as determined by measuring the accumulation of nitrite into the supernatant (data not shown). Protection mediated by preincubation with DETA/NO or proinflammatory cytokines is not affected by low extracellular zinc concentrations (Ͻ1 M), achieved by treating the serum with Chelex. On the contrary, addition of TPEN significantly impaired the protective effects mediated by pretreatment with DETA/NO or proinflammatory cytokines ( Fig. 2A ) toward H 2 O 2 . The NOmediated protection was fully restored if TPEN was titrated with an equimolar concentration of zinc ( Fig. 2A) . These results show that the NO-mediated protection against the toxicity of H 2 O 2 is dependent on intracellular TPEN-chelatable zinc.
To verify whether NO increases the GSH synthesis via "free" zinc, we measured intracellular levels of total GSH 24 h after treating the cells with DETA/NO or proinflammatory cytokines in low-zinc culture medium (prepared with Chelextreated serum) or in the presence of TPEN. We found that DETA/NO increased the total GSH levels more than twofold compared with untreated cells in normal culture medium as well as in low-zinc medium (Fig. 2B) . Addition of TPEN completely abolished the NO-induced increase of GSH, and this inhibition was abrogated by adding an equimolar amount of ZnSO 4 (Fig. 2B) , demonstrating the zinc specificity of the TPEN effect. Together, these findings demonstrate that the DETA/NO induced GSH-synthesis as well as the protection against H 2 O 2 depend on intracellular "free" zinc.
We also examined the effects of cellular NO production on GSH synthesis. In cytokine-treated EC, the total intracellular GSH levels did not differ from that in untreated cells (Fig. 2B) . However, addition of the specific NO synthase inhibitor L-N 5 -(1-iminoethyl)ornithine hydrochloride (L-NIO) significantly decreased cellular GSH levels, indicating that endogenous NO synthesis is needed to maintain the cellular GSH levels under proinflammatory conditions in EC. The same effects were observed in low-zinc medium. In contrast, after TPEN was added (Fig. 2B) , a decrease in the cellular GSH levels was observed. If an equimolar amount of ZnSO 4 was added together with TPEN, the cytokine-induced response was fully restored. Addition of ZnSO 4 to cells treated with cytokines ϩ L-NIO ϩ TPEN restored the GSH levels to a great extent (Fig.  2B) but did not restore cell viability following exposure to H 2 O 2 ( Fig. 2A) . These results show that under proinflammatory conditions, cellular NO synthesis via iNOS as well as intracellular "free" zinc are mainly responsible for maintaining the cellular GSH levels in EC. However, the NO-mediated protection also may include zinc-independent effects.
Exogenously applied NO increases GCLC expression via "free" zinc. We further analyzed the role of GCL in the NO-induced and zinc-mediated protection from H 2 O 2 by analyzing the expression of the catalytic subunit GCLC. We found that DETA/NO increased the expression of Gclc mRNA (Fig.  3A) as well as that of GCLC protein (Fig. 3B) . In the presence of TPEN, DETA/NO failed to increase the expression of Gclc mRNA and GCLC protein levels (Fig. 3, A and B, lane 2) . If an equimolar amount of ZnSO 4 was added together with TPEN, the NO-induced response was fully restored (Fig. 3, A  and B, lane 3) . Thus the NO-induced expression of GCLC is fully dependent on the presence of zinc.
NO-mediated Gclc gene regulation is Nrf2 dependent.
We asked whether the antioxidant transcription factor Nrf2 is involved in the NO-mediated protection against H 2 O 2 . Using immunocytochemistry and laser scanning microscopy, we observed nuclear staining corresponding to Nrf2 in cells treated for 1 h with DETA/NO (Fig. 4BI) or with the established Nrf2 activator tert-butylhydroquinone (tBHQ; 100 M; Fig. 4CI ). Instead, no signal corresponding to Nrf2 was detected in nuclei of untreated cells (Fig. 4AI ). In addition, we found that the silencing of Nrf2 via RNA interference significantly downregulated the basal expression of Gclc mRNA. Moreover, after silencing of Nrf2, neither DETA/NO nor proinflammatory cytokines were effective in inducing the expression of Gclc mRNA in EC (Fig. 5A) . As a control, we verified whether Nrf2 silencing modified the expression of Ho1, which is an established Nrf2 target (2), and similar results were found compared with Gclc (Fig. 5B) . To investigate whether the intracellular "zinc-sensing" transcription factor MTF-1 is involved in the regulation of Gclc, we measured the expression of Gclc and of the MTF-1 target Znt1 after Mtf1 silencing. The absence of MTF-1 did not exert any effect on basal or either DETA/NOor cytokine-induced expression of Gclc (Fig. 5A) . On the other hand, Mtf1 silencing strongly downregulated the basal as well as the DETA/NO-induced expression of Znt1 (Fig. 5C ). This finding shows that Nrf2 but not MTF-1 controls basal as well as zinc-induced expression of Gclc. These results demonstrate that in rat aortic EC, the NO-mediated induction of Gclc mRNA is regulated by Nrf2.
To further control whether DETA/NO induced the expression of Ho1 or Znt1 via intracellular "free" zinc, we measured their mRNA levels after a 24-h incubation with DETA/NO in the presence or absence of TPEN. In the presence of TPEN, DETA/NO failed to increase the expression of Ho1 and Znt1 mRNA (Fig. 6, A and B, lanes 3) . If an equimolar amount of ZnSO 4 was added together with TPEN, the NO-induced responses were fully restored (Fig. 6, A and B, lanes 4) . Thus the Fig. 4 . NO induces the translocation of Nrf2 into the nucleus. EC were seeded on glass coverslips. After 24 h, the cells were washed and cultured for 2 h with medium (A) 1 mM DETA/NO (B), or 100 M tert-butylhydroquinone (tBHQ; C), which is an established Nrf2 activator. Cells were then stained with an anti-Nrf2 antibody (I) and the DNA stain H33342 dye (II). Nrf2 staining (I) and DNA staining (II) were merged to produce the images shown in III.
NO-induced expressions of Ho1 as well as Znt1 are fully dependent on the presence of zinc.
DISCUSSION
NO-mediated protection of EC against H 2 O 2 -induced toxicity.
It has been demonstrated that NO donors as well as iNOS-derived NO protect EC from the cytotoxic effects of H 2 O 2 by various mechanisms including the expression of protective proteins such as HO-1 (50) or Bax and Bcl-2 (63, 65) . To further investigate protective effects of NO, we used the following model system: EC were pretreated for 24 h with either 1 mM DETA/NO or proinflammatory cytokines, which induce the expression of iNOS. Afterward, the cells were washed and then treated with concentrations of H 2 O 2 ranging from 0.2 to 1.4 mM. These H 2 O 2 concentrations are 40 -300 times higher than the 5-15 M range produced by inflammatory cells (42, 67) . However, an initial bolus addition of 1 mM H 2 O 2 will be rapidly consumed in the supernatant of cultured cells and completely destroyed within 2-5 h (53). Pretreatment with exogenously applied or endogenously synthesized NO protects EC from the toxic effects of up to 1. Role of the GSH redox cycle. We found that in rat aortic EC, the NO donor DETA/NO increased the intracellular GSH levels about twofold by increasing the expression of GCLC, which is the catalytic subunit of the rate-limiting enzyme for the GSH de novo synthesis. Similar results have previously been published using bovine aortic EC (46, 47) . We also found that specific inhibition of GCL by BSO completely abolished the NO-induced increases of intracellular GSH as well as the NO-induced protection from the toxic effects of H 2 O 2 . Inhibition of GPx by MS increased the toxicity of H 2 O 2 , as previously shown (12, 21) , and strongly impaired the protection induced by preincubation with DETA/NO. Catalase does not appear to play a role in the NO-mediated protection, because specific inhibition of catalase did not abrogate the protective effect of the DETA/NO pretreatment. These results suggest that GSH itself as well as the GPx activity are necessary for the protection against H 2 O 2 by NO released from NO donors.
We also have analyzed the effects of cellular NO synthesis on the GSH level as well as on the Gclc mRNA expression. The expression of iNOS was induced by treating the cells with proinflammatory cytokines (IL-1␤ ϩ IFN␥) (64) . An increase of iNOS mRNA was observed after 2-4 h of incubation with cytokines, and a significant increase of NO production could already be detected after 6 h as determined by measuring the accumulation of nitrite in the cell culture medium (data not shown). After a 24-h incubation with IL-1␤ ϩ IFN␥, the GSH levels were not different from those in untreated cells, as found by others in a mouse hemoangiotelioma cell line treated with IL-1␤ (68) . In the presence of the specific NOS inhibitor L-NIO, we observed a strong decrease of the Gclc mRNA expression and of the total cellular GSH levels, which correlated with the resistance of the cells toward H 2 O 2 . Thus intracellular NO production is required to maintain the cellular GSH levels under proinflammatory conditions. This is in line with results found with rat hepatocytes, where after stimulation with IL-1␤, an inhibition of NO synthesis by the specific NOS inhibitor N-methyl-L-arginine (L-NMA) resulted in a GSH depletion and a decrease of the GSH/GSSG ratio and Gclc gene transcription (35) . In conclusion, not only NO generated by NO donors but also high-output cellular NO synthesis protect EC against H 2 O 2 by inducing the intracellular de novo synthesis of GSH.
Role of zinc. We recently found that extracellular added zinc induces GSH synthesis by controlling the expression of GCLC, thus protecting EC from H 2 O 2 -induced toxicity (12) . In the same setting as used presently, Berendji et al. (5) showed that treatment with NO donors induces an intracellular zinc release in rat aortic EC, as monitored using the zinc-dependent fluorophore Zinquin. To demonstrate that intracellular zinc released by NO is essential for the increase of the GSH levels and the endothelial protection, we used the membrane-permeable zinc chelator TPEN at a concentration that overwhelms the zinc concentration of the culture medium. In the presence of TPEN, NO fails to induce the GCLC expression, to increase the cellular GSH levels, and, as a consequence, to protect the EC against H 2 O 2 toxicity.
The main limitation of studies about intracellular "free" zinc in biological systems is the lack of metal chelators that only chelate Zn 2ϩ . TPEN has very high affinities for Cu 2ϩ (10 20 . Nevertheless, to control whether the TPEN effects are indeed due to zinc chelation, we added equimolar amounts of zinc in all experiments with TPEN. Addition of zinc always completely abrogated the effects exerted by TPEN, indicating that the TPEN effects are mainly due to the chelation of zinc.
To distinguish between effects of intracellular vs. extracellular zinc chelation (TPEN chelates both), we measured the effects exerted by DETA/NO or proinflammatory cytokines in a medium containing low amounts of zinc (Ͻ1 M). This medium was prepared with Chelex-treated serum, which is the major source of zinc within culture media. Chelex is an ion exchange chelating resin and is not specific for zinc. However, it efficiently removes Zn 2ϩ from buffers or culture media (22, 23, 57) , as verified by us using flame atomic adsorption spectrometry and by others using the more sensitive inductively coupled plasma/absorption emission spectrometry (22) . The effects of DETA/NO or iNOS-derived NO in low-zinc media are not different from the effects measured in the normal zinc-containing media. This indicates that intracellular and not extracellular zinc is required for the NO-mediated protection of EC and the control of the cellular GSH levels. A similar experimental setting was used by Tang et al. (66) , who demonstrated that NO decreases the sensitivity of pulmonary EC to LPS-induced apoptosis in a zinc-dependent fashion.
Under physiological conditions, zinc is redox inert, but it is known to exert antioxidant effects. Our work shows that NO-mediated intracellular zinc release plays a protective role against oxidative damage. In the brain, a deregulation of the neuronal zinc homeostasis has been shown to be strongly linked to a mitochondrial dysfunction and to oxidative stress, making zinc a possible contributor to the activation of pathophysiological pathways (17) . In EC, Wiseman et al. (72) have proposed that an alteration of the intracellular zinc homeostasis may be a mechanism for the H 2 O 2 -mediated toxicity. They (72) showed that H 2 O 2 induces intracellular zinc release and cell death in serum-starved pulmonary artery EC. Addition of 6.5 M TPEN or overexpression of metallothionein to scavenge intracellular Zn 2ϩ decreased the H 2 O 2 -mediated increases in superoxide anion production within the mitochondria as well as the activation of caspases. The authors concluded that intracellular zinc release by H 2 O 2 may result in inappropriate physiological responses, causing oxidative stress and tissue damage. However, the TPEN concentration used was quite high, and effects were only followed up for 4 h (72). In addition, serum starvation depletes cells from zinc, thus rendering them more susceptible to apoptotic stimuli (12, 22, 23) and, in particular, to H 2 O 2 (12) . Thus, as also shown in the present study, preincubation with TPEN increased H 2 O 2 -me- Fig. 7 . NO protects EC against H2O2-induced toxicity via zinc-dependent activation of the GSH redox cycle. In zinc sulfur clusters, zinc ions are tetracoordinated via sulfur (cysteine) and nitrogen (histidine). NO induces zinc release from zinc sulfur clusters of intracellular proteins. This "free" zinc activates the transcription factor Nrf2, which in turn induces the transcription of the Gclc gene. Enhanced expression of GCL, the rate-limiting enzyme of GSH biosynthesis, results in an increased concentration of intracellular GSH, which as a cofactor of GPx is essential to detoxify H2O2 via reduction to H2O. This protective pathway can be inhibited at various points, e.g., by chelating intracellular "free" zinc by TPEN, by Nrf2 silencing (SiNrf2), by translation inhibition via cHEX, by GCL inhibition via BSO, or by GPx inhibition via MS. diated cytotoxicity. It is therefore difficult to compare these results with ours. In contrast to other reactive oxygen species (ROS), the NO-mediated disruption of zinc fingers is reversible (34) . Exogenous applied NO or endogenous NO releases zinc and induces the protective response mediated by GSH. Zinc will then be rebound or sequestrated into intracellular compartments. We speculate that the oxidant damage mediated by H 2 O 2 (and therefore H 2 O 2 -mediated zinc release) is limited by the increased antioxidant capacity of the cells.
It has been shown that there is a correlation between the redox potential of a cell and the amount of "free" zinc within cells, which in turn depends on the total amount of cellular zinc and the zinc-buffering capacity of the cells (31). Large zinc fluctuations are possible at low buffering capacity and high redox potential. In contrast, high buffering capacity and low redox potential limits zinc fluctuation (31) .
Involvement of Nrf2 or of MTF-1?
The transcription factor Nrf2 mainly regulates the expression of proteins that detoxify xenobiotics, reduce oxidized proteins, disrupt redox cycling reactions, maintain the levels of cellular reducing equivalents, inhibit the intracellular generation of ROS, or counteract ROSmediated effects (for review, see Ref. 28) . Data obtained in mouse models as well as in human cells suggest that Nrf2 regulates the expression of GCLC (7, 15, 51, 71) . In addition, Nrf2 knockout mice exhibit a reduced basal expression of Gclc together with an increased sensitivity toward oxidative stress. In the presence of activators, Nrf2 translocates into the nucleus, where it activates the transcription of ARE target genes (26) . Previously, we observed that in rat EC, Nrf2 under basal conditions is localized mainly in the cytoplasm and, after addition of 100 M Zn 2ϩ , translocates into the cell nucleus (12) . Presently, we have shown that NO released from DETA/NO also induces a nuclear translocation of Nrf2. Similar results have been found in rat smooth muscle cells treated with other NO donors (43) . In addition, we have found that Nrf2 silencing results in an inhibition of Gclc mRNA expression induced by NO released from DETA/NO or synthesized by iNOS. As a control, we also investigated the expression of Ho1, which is a well-characterized Nrf2 target gene (2) , and found similar results. Thus, in primary rat EC, the expression of Gclc is induced by NO via Nrf2. Moreover, we found that similarly to Gclc, the NO-induced expression of Ho1 is zinc dependent, pointing to a mechanism where NO induces the expression of Nrf2-dependent genes via zinc and Nrf2.
Studies have indicated that the zinc-sensing transcription factor MTF-1, which binds to metal response elements (MREs), also may regulate Gclc gene expression (19, 51) . In fact, MREs are present in the promoter of both mouse (19) and human Gclc (51) , and a strongly reduced basal expression of Gclc has been observed in Mtf1 knockout mice (19) . Although it is well known that zinc may regulate gene transcription via activation of MTF-1, we found that silencing of Mtf1 did not affect either the basal or the NO-induced transcription of rat Gclc, whereas it inhibited the basal as well as the NO-induced expression of Znt1, a typical MTF-1 target gene (36) . Thus Nrf2, and not MTF-1, is the predominant regulator of Gclc expression in rat EC. Using other approaches, Yang et al. (75) found that Nrf2 is essential for the regulation of Gclc expression in the rat. Li et al. (40) recently identified a putative ARE sequence 4 kb upstream of the rat GCLC promoter. Of interest, NO-induced expression of Znt1 in EC was both MTF-1 dependent and inhibited by addition of TPEN, as shown previously in HepG2 cells (11) . This indicates that NO-mediated gene expression may act via MTF-1 in genes other than Gclc.
The molecular mechanism underlying the activation of Nrf2 has not been completely elucidated so far. Keap1 (Kelch-like ECH-associated protein-1) binds to Nrf2, thus targeting it for ubiquitination and proteolytic degradation, and as such is responsible for the rapid Nrf2 turnover. Compounds that react with Keap1 result in subsequent nuclear translocation of Nrf2. Recombinant murine Keap1 in vitro binds zinc via two cysteine SH residues (14) . Electrophiles or ROS have been found to cause cysteine modifications, which results in zinc release and subsequent profound conformational changes of Keap1 in vitro (14) . When EC are activated with proinflammatory cytokines, they also increase their ROS levels, and ROS are known to activate the Keap1-Nrf2/ARE pathway. Thus, in addition to the NO and zinc-dependent pathway, ROS produced by cytokines may directly inactivate Keap1. Recently, NO also has been identified to cause Keap1 thiol modification in cells (6) . Therefore, Keap1 is an excellent candidate as a sensor for NO.
Conclusions. Zinc has been named a "second messenger" (74) and the "calcium of the twenty-first century" (18) . Our results suggest that intracellularly released ("free") zinc may indeed exert a signaling function in the NO-mediated protection of EC from oxidative stress-mediated cell death. Zinc signals emerge as integrate members of redox signaling networks (Fig. 7) . In addition, it has been proposed that an inadequate zinc concentration in the plasma or in vascular tissues may be involved in the initiation of cell injury, the amplification of oxidative stress and inflammation, or the lack of protection against apoptosis, all of which are key events leading to endothelial dysfunction and vascular disease (3) . We have shown in the present study that chelation of intracellular "free" zinc limits the protective activity of NO. Thus the data presented may explain why the maintenance of an adequate zinc status in the endothelium is important to protect from oxidative stress and the development of vascular diseases.
